Irene Russo, Sara Cazzolla, Francesca Pampaloni, & Mauro Alaibac. (2022). Omalizumab for the treatment of chronic spontaneous urticaria: Association between body mass index and outcome. Mattioli1885.
Chicago Style (17th ed.) CitationIrene Russo, Sara Cazzolla, Francesca Pampaloni, and Mauro Alaibac. Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome. Mattioli1885, 2022.
MLA (9th ed.) CitationIrene Russo, et al. Omalizumab for the Treatment of Chronic Spontaneous Urticaria: Association Between Body Mass Index and Outcome. Mattioli1885, 2022.
Warning: These citations may not always be 100% accurate.